−Beta-blockade

+Beta-blockade

N

75

102

Male, %

66

78*

Age in years, mean (SD)

62 (9)

63 (7)

Resting PPS, (arbitrary units), mean (SD)

76.6 (13.0)

78.3 (13.0)

MDI, (arbitrary units), mean (SD)

9.4 (6.8)

8.6 (7.5)

PPS response to TTT, (arbitrary units), mean (SD)

−5.4 (11.6)

−4.7 (14.2)

Systolic blood pressure (SBP) response to TTT, (mmHg), mean (SD)

−3.3 (13.1)

−2.3 (12.3)

Cardiac variables

Previous myocardial infarction (%)

63

68

Treated with PCI (%)

64

73

Treated with CABG (%)

23

31

Resting pulse, (beats/min), mean (SD)

64 (11)

59 (9)**

SBP, (mmHg), mean (SD)

134 (16)

1330 (17)

Diastolic blood pressure, (mmHg), mean (SD)

789(9)

80 (9)

Cardiac risk factors

Body Mass Index, (kg/m2), mean (SD)

27.4 (4.8)

27.6 (4)

Triglyceride, (mmol/l), mean (SD)

1.3 (0.8)

1.5 (0.9)

Total Cholesterol, (mmol/l), mean (SD)

4.4 (1.0)

4.3 (1.0)

HDL Cholesterol, (mmol/l), mean (SD)

1.3 (0.4)

1.2 (0.4)

LDL Cholesterol, (mmol/l), mean (SD)

2.5 (0.8)

2.3 (0.8)

Current smoker (%)

2

2

Self-reported co-morbidity

Heart failure (%)

19

44***

Chronic obstructive lung disease (%)

5

9

Diabetes (%)

12

15

Previous stroke (%)

6

8

Previous treatment for depression (%)

16

14

Medication

Cholesterol-lowering medication (%)

85

96

Calcium antagonists (%)

19

25

Angiotensin-II antagonist and/or ACE inhibitors (%)

51

59

Diuretics (thiazide or furosemide) (%)

33

35